72 related articles for article (PubMed ID: 1694021)
21. The variation of risk estimates through pregnancy in second trimester maternal serum screening for Down syndrome.
Christiansen M; Høgdall EV; Larsen SO; Høgdall C
Prenat Diagn; 2002 May; 22(5):385-7. PubMed ID: 12001192
[TBL] [Abstract][Full Text] [Related]
22. The role of maternal serum alpha-fetoprotein, human chorionic gonadotrophin and oestriol in the antenatal screening of Down's syndrome.
Chang TC; Cheng HH
Med J Malaysia; 1994 Dec; 49(4):351-4. PubMed ID: 7545778
[TBL] [Abstract][Full Text] [Related]
23. Maternal serum testing for alpha-fetoprotein and human chorionic gonadotropin in high-risk pregnancies.
Jauniaux E; Gulbis B; Tunkel S; Ramsay B; Campbell S; Meuris S
Prenat Diagn; 1996 Dec; 16(12):1129-35. PubMed ID: 8994249
[TBL] [Abstract][Full Text] [Related]
24. Maternal serum-integrated screening for trisomy 18 using both first- and second-trimester markers.
Palomaki GE; Neveux LM; Knight GJ; Haddow JE
Prenat Diagn; 2003 Mar; 23(3):243-7. PubMed ID: 12627428
[TBL] [Abstract][Full Text] [Related]
25. Maternal serum screening for birth defects: results of a Connecticut regional program.
Benn PA; Horne D; Craffey A; Collins R; Ramsdell L; Greenstein R
Conn Med; 1996 Jun; 60(6):323-7. PubMed ID: 8706425
[TBL] [Abstract][Full Text] [Related]
26. [Hormone analyses and ultrasound examinations in high-risk early weeks of pregnancy (author's transl)].
Gerhard I; Runnebaum B; Kubli F
Z Geburtshilfe Perinatol; 1979 Oct; 183(5):323-34. PubMed ID: 396727
[TBL] [Abstract][Full Text] [Related]
27. [Prenatal screening for major fetal defects by using of maternal serum markers].
Bao P; Wu Y; Gu Q
Zhonghua Fu Chan Ke Za Zhi; 1997 Nov; 32(11):649-51. PubMed ID: 9639762
[TBL] [Abstract][Full Text] [Related]
28. Multiple-marker screening for Down's syndrome: a method of assessing the statistical robustness of proposed tests.
Morris JK; Bestwick J; Wald NJ
J Med Screen; 2008; 15(2):55-61. PubMed ID: 18573771
[TBL] [Abstract][Full Text] [Related]
29. First and second-trimester biochemical markers of chromosomal anomalies and their relationship to maternal haemoglobin levels.
Cowans NJ; Spencer K
Prenat Diagn; 2005 Aug; 25(8):693-9. PubMed ID: 16050001
[TBL] [Abstract][Full Text] [Related]
30. Second trimester serum markers.
Canick JA; MacRae AR
Semin Perinatol; 2005 Aug; 29(4):203-8. PubMed ID: 16104669
[TBL] [Abstract][Full Text] [Related]
31. Prediction of fetal growth based on maternal serum concentrations of human chorionic gonadotropin, human placental lactogen and estriol.
Markestad T; Bergsjø P; Aakvaag A; Lie RT; Jacobsen G; Hoffman HJ; Bakketeig LS
Acta Obstet Gynecol Scand Suppl; 1997; 165():50-5. PubMed ID: 9219457
[TBL] [Abstract][Full Text] [Related]
32. Triploidy identified through second-trimester serum screening.
Huang T; Alberman E; Wald N; Summers AM
Prenat Diagn; 2005 Mar; 25(3):229-33. PubMed ID: 15791661
[TBL] [Abstract][Full Text] [Related]
33. Pregnancy outcome in women with low midtrimester maternal serum unconjugated estriol.
Santolaya-Forgas J; Jessup J; Burd LI; Prins GS; Burton BK
J Reprod Med; 1996 Feb; 41(2):87-90. PubMed ID: 8656420
[TBL] [Abstract][Full Text] [Related]
34. Placental mosaicism is associated with unexplained second-trimester elevation of MShCG levels, but not with elevation of MSAFP levels.
Morssink LP; Sikkema-Raddatz B; Beekhuis JR; De Wolf BT; Mantingh A
Prenat Diagn; 1996 Sep; 16(9):845-51. PubMed ID: 8905899
[TBL] [Abstract][Full Text] [Related]
35. Down syndrome: prenatal risk assessment and diagnosis.
Newberger DS
Am Fam Physician; 2000 Aug; 62(4):825-32, 837-8. PubMed ID: 10969860
[TBL] [Abstract][Full Text] [Related]
36. Comparison of urinary hyperglycosylated human chorionic gonadotropin concentration with the serum triple screen for Down syndrome detection in high-risk pregnancies.
Bahado-Singh RO; Oz U; Shahabi S; Mahoney MJ; Baumgarten A; Cole LA
Am J Obstet Gynecol; 2000 Nov; 183(5):1114-8. PubMed ID: 11084551
[TBL] [Abstract][Full Text] [Related]
37. Preliminary evidence for associations between second-trimester human chorionic gonadotropin and unconjugated oestriol levels with pregnancy outcome in Down syndrome pregnancies.
Benn PA
Prenat Diagn; 1998 Apr; 18(4):319-24. PubMed ID: 9602476
[TBL] [Abstract][Full Text] [Related]
38. Predicting the result of additional second-trimester markers from a woman's first-trimester marker profile: a new concept in Down syndrome screening.
Maymon R; Cuckle H; Jones R; Reish O; Sharony R; Herman A
Prenat Diagn; 2005 Dec; 25(12):1102-6. PubMed ID: 16231324
[TBL] [Abstract][Full Text] [Related]
39. First-trimester biochemical markers of aneuploidy and the prediction of small-for-gestational age fetuses.
Spencer K; Cowans NJ; Avgidou K; Molina F; Nicolaides KH
Ultrasound Obstet Gynecol; 2008 Jan; 31(1):15-9. PubMed ID: 17999381
[TBL] [Abstract][Full Text] [Related]
40. Hormone levels in amniotic fluid and fetal sex.
Bremme K; Eneroth P; Nilsson B
Gynecol Obstet Invest; 1982; 14(4):245-62. PubMed ID: 6184270
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
